GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » China Healthwise Holdings Ltd (HKSE:00348) » Definitions » 3-Year RORE %

China Healthwise Holdings (HKSE:00348) 3-Year RORE % : 9.97% (As of Dec. 2023)


View and export this data going back to 1997. Start your Free Trial

What is China Healthwise Holdings 3-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. China Healthwise Holdings's 3-Year RORE % for the quarter that ended in Dec. 2023 was 9.97%.

The industry rank for China Healthwise Holdings's 3-Year RORE % or its related term are showing as below:

HKSE:00348's 3-Year RORE % is ranked better than
61.19% of 590 companies
in the Healthcare Providers & Services industry
Industry Median: 0.085 vs HKSE:00348: 9.97

China Healthwise Holdings 3-Year RORE % Historical Data

The historical data trend for China Healthwise Holdings's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Healthwise Holdings 3-Year RORE % Chart

China Healthwise Holdings Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Dec20 Dec21 Dec22 Dec23
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -37.25 - - 16.32 9.97

China Healthwise Holdings Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 21.00 16.32 66.67 9.97

Competitive Comparison of China Healthwise Holdings's 3-Year RORE %

For the Pharmaceutical Retailers subindustry, China Healthwise Holdings's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Healthwise Holdings's 3-Year RORE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, China Healthwise Holdings's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where China Healthwise Holdings's 3-Year RORE % falls into.



China Healthwise Holdings 3-Year RORE % Calculation

China Healthwise Holdings's 3-Year RORE % for the quarter that ended in Dec. 2023 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -0.174--0.136 )/( -0.381-0 )
=-0.038/-0.381
=9.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2023 and 3-year before.


China Healthwise Holdings  (HKSE:00348) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


China Healthwise Holdings 3-Year RORE % Related Terms

Thank you for viewing the detailed overview of China Healthwise Holdings's 3-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


China Healthwise Holdings (HKSE:00348) Business Description

Traded in Other Exchanges
N/A
Address
168-200 Connaught Road Central, Unit 1209, Shun Tak Centre, West Tower, Hong Kong, HKG
China Healthwise Holdings Ltd is an investment holding company. It operates in three segments: Chinese health products, Money lending business, and investment in financial instruments. The majority of its revenue comes from trading in Chinese health products, which include pharmaceutical products, ginseng, and dried seafood products. The company's geographical segments are Hong Kong and the PRC, of which key revenue is derived from Hong Kong.
Executives
Eternity Investment Limited 2201 Interest of corporation controlled by you
Heng Tai Consumables Group Limited 2201 Interest of corporation controlled by you
Heng Tai Finance Limited 2101 Beneficial owner
Lei Hong Wai 2101 Beneficial owner

China Healthwise Holdings (HKSE:00348) Headlines

No Headlines